Cargando…

Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant

Introduction: Cytomegalovirus (CMV) is the leading opportunistic infection in lung transplant (LTx) recipients. CMV is associated with graft failure and decreased survival. Recently, new antiviral therapies have been proposed. The present study aimed to investigate NK and T cell subsets of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergantini, Laura, d’Alessandro, Miriana, Otranto, Ambra, Cavallaro, Dalila, Gangi, Sara, Fossi, Antonella, Perillo, Felice, Luzzi, Luca, Zanfrini, Edoardo, Paladini, Piero, Sestini, Piersante, Rottoli, Paola, Bargagli, Elena, Bennett, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325149/ https://www.ncbi.nlm.nih.gov/pubmed/35888169 http://dx.doi.org/10.3390/life12071081

Ejemplares similares

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution
por: Bergantini, Laura, et al.
Publicado: (2021)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
por: Bergantini, Laura, et al.
Publicado: (2021)

Serum Amyloid A in lung transplantation
por: Vietri, Lucia, et al.
Publicado: (2020)

Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients
por: Bocci, Silvia, et al.
Publicado: (2023)

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
por: Cameli, Paolo, et al.
Publicado: (2020)

Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis
por: Bergantini, Laura, et al.
Publicado: (2022)

Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
por: Bergantini, Laura, et al.
Publicado: (2021)

Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study
por: Cameli, Paolo, et al.
Publicado: (2021)

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
por: Bergantini, Laura, et al.
Publicado: (2022)

Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases
por: Viani, Magda, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
por: Vietri, Lucia, et al.
Publicado: (2020)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis
por: Refini, Rosa Metella, et al.
Publicado: (2020)

Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases
por: Bergantini, Laura, et al.
Publicado: (2020)

Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
por: Cameli, Paolo, et al.
Publicado: (2020)

Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series
por: Bergantini, Laura, et al.
Publicado: (2022)

CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis
por: Bergantini, Laura, et al.
Publicado: (2022)

Immunological Pathways in Sarcoidosis and Autoimmune Rheumatic Disorders—Similarities and Differences in an Italian Prospective Real-Life Preliminary Study
por: d’Alessandro, Miriana, et al.
Publicado: (2023)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Clinical phenotyping in sarcoidosis management
por: Rana, Giuseppe Domenico, et al.
Publicado: (2021)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
por: Cameli, Paolo, et al.
Publicado: (2022)

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
por: Bergantini, Laura, et al.
Publicado: (2019)

Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
por: Cavallaro, Dalila, et al.
Publicado: (2022)

Effect of Ambulatory Oxygen on the Respiratory Pattern during the 6 Min Walking Test in Patients with Interstitial Lung Diseases
por: Ventura, Vittoria, et al.
Publicado: (2023)

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility
por: Cameli, Paolo, et al.
Publicado: (2020)

Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence
por: Armati, M., et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy
por: Landi, Claudia, et al.
Publicado: (2020)

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis Patients
por: d’Alessandro, Miriana, et al.
Publicado: (2023)

Prognostic Significance of Obstructive Sleep Apnea in a Population of Subjects with Interstitial Lung Diseases
por: Valecchi, Debora, et al.
Publicado: (2023)

Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients
por: Bergantini, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvgo1n993ujjnfjlpapuf7ihlr